Showing 41-50 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
Pro-Angiogenic and Immune-Modulatory Scaffolds for the Functional Engraftment of Islets in the Subcutaneous Space Carnegie Mellon University Adam Feinberg Cures 01-November-2024 to 31-October-2027 $950,000.00
microRNA-146a is a potential therapeutic target for type 1 diabetes Case Western Reserve University Parameswaran Ramakrishnan Cures 01-June-2024 to 31-May-2027 $600,000.00
Novel mechanism and method to control T cell mediated autoimmunity in type 1 diabetes Case Western Reserve University Parameswaran Ramakrishnan Cures 01-June-2022 to 31-May-2027 $600,000.00
Engineering and Translational Control of Vascularization for Durable Islet Replacement Therapies Cedars-Sinai Medical Center Dhruv Sareen Cures 01-October-2026 to 30-September-2029 $899,998.80
Scalable GMP-Compliant Manufacturing of iPSC-Derived Insulin-Producing Cells: From Seed Train to Cryopreserved Product Cedars-Sinai Medical Center Dhruv Sareen Cures 01-April-2026 to 31-March-2028 $600,000.00
Leveraging humoral immunity to promote commensal microbial protection from T1D Children’s Hospital of Philadelphia Michael Silverman Cures 01-May-2020 to 30-April-2026 $749,994.60
Spotlight-AQ 2 Center RCT Children’s Mercy Hospital Cintya Schweisberger Improving Lives 01-September-2023 to 31-August-2026 $710,434.16
Acute Hyperglycemia Promotes a Proinflammatory Monocyte Phenotype to Drive Glomerular Injury in People with Diabetic Kidney Disease and Type 1 Diabetes Cleveland Clinic Foundation Rong Mei Zhang Improving Lives 01-July-2026 to 31-December-2027 $74,999.40
Closing the T1D diagnosis gap in Ethiopia, Ghana and Nigeria Clinton Health Access Initiative (CHAI) Margaret Prust Mission 01-September-2023 to 31-August-2026 $1,702,076.57
ALIGN-T1D Start-Up Secretariat Clinton Health Access Initiative (CHAI) Colin Brown Mission 01-October-2025 to 31-March-2027 $822,000.00